GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dar Al Dawa Development and Investment (AMM:DADI) » Definitions » 3-Year FCF Growth Rate

Dar Al Dawa Development and Investment (AMM:DADI) 3-Year FCF Growth Rate : 5.90% (As of Mar. 2024)


View and export this data going back to 1978. Start your Free Trial

What is Dar Al Dawa Development and Investment 3-Year FCF Growth Rate?

Dar Al Dawa Development and Investment's Free Cash Flow per Share for the three months ended in Mar. 2024 was JOD-0.08.

During the past 12 months, Dar Al Dawa Development and Investment's average Free Cash Flow per Share Growth Rate was 300.00% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 5.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Dar Al Dawa Development and Investment was 134.80% per year. The lowest was -39.10% per year. And the median was -7.20% per year.


Competitive Comparison of Dar Al Dawa Development and Investment's 3-Year FCF Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Dar Al Dawa Development and Investment's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dar Al Dawa Development and Investment's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dar Al Dawa Development and Investment's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Dar Al Dawa Development and Investment's 3-Year FCF Growth Rate falls into.



Dar Al Dawa Development and Investment 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Dar Al Dawa Development and Investment  (AMM:DADI) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Dar Al Dawa Development and Investment 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Dar Al Dawa Development and Investment's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Dar Al Dawa Development and Investment (AMM:DADI) Business Description

Traded in Other Exchanges
N/A
Address
Naour, P.O. Box 9364, Amman, JOR, 11191
Dar Al Dawa Development and Investment is a pharmaceutical company. The main objectives of the company are to manufacture pharmaceutical, chemical, pharmaceutical, and related products and to import medicines. It offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, dermatology, eye-ear preparations, gastroenterology and metabolism, genitourinary system and sex hormones, musculoskeletal system, nervous system, ophthalmological/otological, and respiratory system, as well as vitamins. The company's geographical segments are Levant and Iraq, Gulf and Yemen, Africa, and Europe and Asia.

Dar Al Dawa Development and Investment (AMM:DADI) Headlines

No Headlines